Abstract
25
expressing an MHC-I restricted epitope from influenza A virus (IAV) H1N1 within the immediate 26 early 2 (ie2) gene. Only mice that were immunized intranasally (i.n.) were capable of controlling 27 IAV infection, despite the greater potency of the intraperitoneally (i.p.) vaccination in inducing 28 a systemic IAV-specific CD8 + T cell response. The protective capacity of the i.n. immunization 29 was associated with its ability to induce IAV-specific tissue-resident memory CD8 + T (CD8T RM ) 30 cells in the lungs. Our data demonstrate that the protective effect exerted by the i.n. 242 Therefore, we measured the production of IFNγ in the bronchoalveolar lavage fluid (BALF) 243 early upon challenge. IFNγ levels were generally low at day 2 post-challenge and no difference 244 could be observed between groups regardless of airway CD8 + T cells depletion ( Fig 5C) . On 245 day 4, the IFNγ level was significantly increased compared to the level on day 2, but more
246
IFNγ was induced in the control group than in the one lacking airway CD8 + T cell in the lungs 
293
Anti-CD45 antibodies were injected i.v. 3-5 min prior to euthanasia and organ collection. The 294 IVL-specific CD8 + T cell population failed to expand upon airway CD8 + T cell depletion, with 295 significantly lower numbers in CD45 -subset on day 4. IAV-specific CD8 + T cell counts showed 296 an increased trend both in the CD45 + and in the CD45 -subsets on day 4 post-challenge (Fig   297  6E ). Airway CD8 + T cell depletion prevented also the expansion of total CD8 + T cells counts on 298 day 4 (Fig 6F) . Interestingly, only the CD45 unlabeled fraction of the total CD8 pool expanded 299 on day 4 (Fig 6F) , in contrast to IVL-specific CD8 + T cells, where CD45 + cells also expanded 300 (Fig 6E) . It is important to note that the number of total CD45 -CD8 + T cells increased in the i.n.
301
immunization group, arguing that the recruitment by CD8T RM cells was antigen-independent.
302
Thus, non-cognate antigen-specific cells were also attracted from the circulation to the lungs 303 and this accumulation of cells was abrogated by mucosal CD8 + T cell depletion (Fig 6F) .
304
We surmised that the accumulation of CD8 + T cells in the lungs and in the BALF might be due 305 to an expansion of CD8T RM upon IAV challenge. Surprisingly, the number of CD8T RM cells in 306 the lungs did not expand from day 2 to day 4; if anything, their frequency decreased (Figs 7A 307 and 7B). Likewise, IVL-Tetramer + CD8T RM cell counts were also slightly reduced from day 2 to 308 day 4 post-challenge (Fig 7C) , although IVL-Tetramer + CD8 counts in the BALF increased at 309 the same time (Fig 6A) . It is important to note that the effect of the i.n. depletion was local, 
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Recombinant MCMV was generated by the ''en passant mutagenesis'', essentially as 412 described previously [55, 56] . In brief, we generated a construct containing an antibiotic 413 resistance cassette coupled with the insertion sequence and the restriction site Sce-I. This 
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Virus in vitro infection
436 NIH-3T3 cell monolayers were infected with MCMV WT and MCMV IVL at an MOI of 0.1, incubated 437 at 37°C for 1h, upon which the inoculum was removed, cells were washed with PBS, and 438 supplied with fresh medium. Cells were incubated for 6 days; the supernatant was harvested 439 every day and stored at -80°C until titration.
440
Virus in vivo infection 
448
Infectious virus quantification (MCMV)
449 MCMV virus from organ homogenates was titrated on MEFs with centrifugal enhancement as 450 described previously [17] .
451
Infectious virus quantification (IAV)
452
Mice were sacrificed by CO 2 inhalation, whole lungs were excised and mechanically 453 homogenized using a tissue homogenizer. Tissue homogenates were spun down and 454 supernatants were stored at -70°C. Lung virus titers were determined by using the focus- 
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Isolation of lymphocytes from blood and organs 467 Blood, spleen and mLNs were prepared as described previously [31] . Lungs were perfused by 468 injecting 5-10 ml PBS into the right heart ventricle. The lungs were cut into small pieces, 469 resuspended in 1 ml RPMI1640 (0.5% FCS), and digested with 1 ml of RPMI1640 with DNase 470 I (Sigma-Aldrich Chemie) and Collagenase I (ROCKLAND TM ) in a shaker at 37°C for 30 min.
471
Digested tissue was passed through cell strainers and single cell suspensions were washed 472 with RPMI1640, centrifuged at 500x g for 10 min. Subsequently, the cells were resuspended 473 in 7 ml of 40% Easycoll solution (Biochrom), overlayed onto 6 ml of 70% Easycoll solution in a 474 15 ml Falcon and centrifuged at 25 min at 1000x g at room temperature. The interface layer 475 was transferred to a 5 ml tube, washed, and resuspended in RPMI1640 (10% FCS).
476
Peptide stimulation 477 T cells were stimulated with peptides (1 µg/ml) in 85 µl RPMI 1640 for 1h at 37°C, 
500
Collection of bronchoalveolar lavage fluid (BALF) 501
Mice were sacrificed by CO 2 inhalation, chest cavity was opened and skin and muscle around 502 the neck were gently removed to expose the trachea. A catheter was inserted and lungs were 503 carefully flushed with 1 mL PBS via the trachea. The BALF was transferred into a 1.5 ml tube 504 and stored on ice. The BALF was centrifuged at 500x g at 4°C for 10 min. Supernatant was 505 aliquoted and stored at -80°C until further analysis.
506
Cytokine and chemokine quantification 
